Ingen interaktion forventes hos mennesker, da systemiske koncentrationer af bimatoprost er ekstremt lave (under 0, 2 ng/ ml) efter okulær dosering.
No interactions are anticipated in humans, since systemic concentrations of bimatoprost are extremely low (less than 0.2 ng/ ml) following ocular dosing.